Bio Techne Corp Stock Performance
| TECH Stock | USD 57.92 0.05 0.09% |
The firm shows a Beta (market volatility) of 0.21, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Bio Techne's returns are expected to increase less than the market. However, during the bear market, the loss of holding Bio Techne is expected to be smaller as well. At this point, Bio Techne Corp has a negative expected return of -0.13%. Please make sure to confirm Bio Techne's expected short fall, day median price, and the relationship between the potential upside and accumulation distribution , to decide if Bio Techne Corp performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Bio Techne Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest uncertain performance, the Stock's fundamental indicators remain strong and the recent confusion on Wall Street may also be a sign of long-lasting gains for the firm traders. ...more
Actual Historical Performance (%)
One Day Return 1.86 | Five Day Return 2.25 | Year To Date Return (1.09) | Ten Year Return 174.93 | All Time Return 53.8 K |
Forward Dividend Yield 0.0054 | Payout Ratio | Last Split Factor 4:1 | Forward Dividend Rate 0.32 | Dividend Date 2026-02-27 |
1 | CSLLY or TECH Which Is the Better Value Stock Right Now | 01/30/2026 |
2 | Bio-Techne Releases Second Quarter Fiscal 2026 Results | 02/04/2026 |
3 | TECH Q4 Deep Dive Margin Expansion and Flat Revenue Amid Mixed End Markets | 02/05/2026 |
4 | There May Be Reason For Hope In Bio-Technes Disappointing Earnings | 02/11/2026 |
5 | Principal Financial Group Inc. Sells 35,059 Shares of Bio-Techne Corp TECH | 02/13/2026 |
6 | Will Bio-Techne Turn Ellas EU Clinical Clearance Into A Precision-Medicine Edge | 02/17/2026 |
| Bio Techne dividend paid on 28th of February 2026 | 02/28/2026 |
| Begin Period Cash Flow | 151.8 M | |
| Total Cashflows From Investing Activities | -35.2 M |
Bio Techne Relative Risk vs. Return Landscape
If you would invest 6,367 in Bio Techne Corp on November 30, 2025 and sell it today you would lose (575.00) from holding Bio Techne Corp or give up 9.03% of portfolio value over 90 days. Bio Techne Corp is currently does not generate positive expected returns and assumes 2.378% risk (volatility on return distribution) over the 90 days horizon. In different words, 21% of stocks are less volatile than Bio, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Bio Techne Target Price Odds to finish over Current Price
The tendency of Bio Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 57.92 | 90 days | 57.92 | about 87.41 |
Based on a normal probability distribution, the odds of Bio Techne to move above the current price in 90 days from now is about 87.41 (This Bio Techne Corp probability density function shows the probability of Bio Stock to fall within a particular range of prices over 90 days) .
Bio Techne Price Density |
| Price |
Predictive Modules for Bio Techne
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Bio Techne Corp. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Bio Techne's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Bio Techne Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Bio Techne is not an exception. The market had few large corrections towards the Bio Techne's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Bio Techne Corp, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Bio Techne within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.02 | |
β | Beta against Dow Jones | 0.21 | |
σ | Overall volatility | 4.04 | |
Ir | Information ratio | -0.03 |
Bio Techne Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Bio Techne for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Bio Techne Corp can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Bio Techne Corp generated a negative expected return over the last 90 days | |
| Over 99.0% of the company shares are owned by institutional investors | |
| On 28th of February 2026 Bio Techne paid $ 0.08 per share dividend to its current shareholders | |
| Latest headline from simplywall.st: Will Bio-Techne Turn Ellas EU Clinical Clearance Into A Precision-Medicine Edge |
Bio Techne Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Bio Stock often depends not only on the future outlook of the current and potential Bio Techne's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Bio Techne's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 159.7 M | |
| Cash And Short Term Investments | 162.2 M |
Bio Techne Fundamentals Growth
Bio Stock prices reflect investors' perceptions of the future prospects and financial health of Bio Techne, and Bio Techne fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Bio Stock performance.
| Return On Equity | 0.0397 | ||||
| Return On Asset | 0.0652 | ||||
| Profit Margin | 0.07 % | ||||
| Operating Margin | 0.20 % | ||||
| Current Valuation | 9.24 B | ||||
| Shares Outstanding | 156.45 M | ||||
| Price To Earning | 74.38 X | ||||
| Price To Book | 4.51 X | ||||
| Price To Sales | 7.59 X | ||||
| Revenue | 1.22 B | ||||
| Gross Profit | 809.63 M | ||||
| EBITDA | 216.88 M | ||||
| Net Income | 73.4 M | ||||
| Cash And Equivalents | 247.03 M | ||||
| Cash Per Share | 6.30 X | ||||
| Total Debt | 444.06 M | ||||
| Debt To Equity | 0.19 % | ||||
| Current Ratio | 3.44 X | ||||
| Book Value Per Share | 12.90 X | ||||
| Cash Flow From Operations | 287.56 M | ||||
| Earnings Per Share | 0.53 X | ||||
| Market Capitalization | 9.23 B | ||||
| Total Asset | 2.56 B | ||||
| Retained Earnings | 1.07 B | ||||
| Working Capital | 432.45 M | ||||
| Current Asset | 253.89 M | ||||
| Current Liabilities | 54.15 M | ||||
About Bio Techne Performance
By evaluating Bio Techne's fundamental ratios, stakeholders can gain valuable insights into Bio Techne's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Bio Techne has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Bio Techne has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 144.94 | 86.64 | |
| Return On Tangible Assets | 0.05 | 0.05 | |
| Return On Capital Employed | 0.05 | 0.05 | |
| Return On Assets | 0.03 | 0.03 | |
| Return On Equity | 0.04 | 0.04 |
Things to note about Bio Techne Corp performance evaluation
Checking the ongoing alerts about Bio Techne for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Bio Techne Corp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Bio Techne Corp generated a negative expected return over the last 90 days | |
| Over 99.0% of the company shares are owned by institutional investors | |
| On 28th of February 2026 Bio Techne paid $ 0.08 per share dividend to its current shareholders | |
| Latest headline from simplywall.st: Will Bio-Techne Turn Ellas EU Clinical Clearance Into A Precision-Medicine Edge |
- Analyzing Bio Techne's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Bio Techne's stock is overvalued or undervalued compared to its peers.
- Examining Bio Techne's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Bio Techne's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Bio Techne's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Bio Techne's stock. These opinions can provide insight into Bio Techne's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Bio Stock analysis
When running Bio Techne's price analysis, check to measure Bio Techne's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bio Techne is operating at the current time. Most of Bio Techne's value examination focuses on studying past and present price action to predict the probability of Bio Techne's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bio Techne's price. Additionally, you may evaluate how the addition of Bio Techne to your portfolios can decrease your overall portfolio volatility.
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Stocks Directory Find actively traded stocks across global markets | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |